Abstract:We present the design and \textit{in-silico} evaluation of a closed-loop insulin delivery algorithm to treat type 1 diabetes (T1D) consisting in a data-driven multi-step-ahead blood glucose (BG) predictor integrated into a Linear Time-Varying (LTV) Model Predictive Control (MPC) framework. Instead of identifying an open-loop model of the glucoregulatory system from available data, we propose to directly fit the entire BG prediction over a predefined prediction horizon to be used in the MPC, as a nonlinear function of past input-ouput data and an affine function of future insulin control inputs. For the nonlinear part, a Long Short-Term Memory (LSTM) network is proposed, while for the affine component a linear regression model is chosen. To assess benefits and drawbacks when compared to a traditional linear MPC based on an auto-regressive with exogenous (ARX) input model identified from data, we evaluated the proposed LSTM-MPC controller in three simulation scenarios: a nominal case with 3 meals per day, a random meal disturbances case where meals were generated with a recently published meal generator, and a case with 25$\%$ decrease in the insulin sensitivity. Further, in all the scenarios, no feedforward meal bolus was administered. For the more challenging random meal generation scenario, the mean $\pm$ standard deviation percent time in the range 70-180 [mg/dL] was 74.99 $\pm$ 7.09 vs. 54.15 $\pm$ 14.89, the mean $\pm$ standard deviation percent time in the tighter range 70-140 [mg/dL] was 47.78$\pm$8.55 vs. 34.62 $\pm$9.04, while the mean $\pm$ standard deviation percent time in sever hypoglycemia, i.e., $<$ 54 [mg/dl] was 1.00$\pm$3.18 vs. 9.45$\pm$11.71, for our proposed LSTM-MPC controller and the traditional ARX-MPC, respectively. Our approach provided accurate predictions of future glucose concentrations and good closed-loop performances of the overall MPC controller.

Extended Kalman filter state estimation-based nonlinear explicit model predictive control design for blood glucose regulation of type 1 diabetic patient

An Automatic Insulin Infusion System Based on Kalman Filtering Model Predictive Control Technique

Simultaneous model predictive control and moving horizon estimation for blood glucose regulation in Type 1 diabetes

Event-Triggered Model Predictive Control for Artificial Pancreas Using Prior-Knowledge-Informed Hybrid Model

Insulin Dosage Optimization Based on Model Predictive Control with the Model Parameters Estimation

Prior-knowledge-embedded Model Predictive Control for Blood Glucose Regulation: Towards Efficient and Safe Artificial Pancreas

Design of reduced multiple model predictive controller for glucose–insulin regulation in type 1 diabetic patients

Model Predictive Control (MPC) of an Artificial Pancreas with Data-Driven Learning of Multi-Step-Ahead Blood Glucose Predictors

A practical approach based on learning-based model predictive control with minimal prior knowledge of patients for artificial pancreas

Insulin infusion rate control using information theoretic–based nonlinear model predictive control for type 1 diabetes patients

Blood glucose regulation in type 1 diabetic patients: an adaptive parametric compensation control‐based approach

Blood glucose regulation and control of insulin and glucagon infusion using single model predictive control for type 1 diabetes mellitus

Gaussian Process-Based Model Predictive Control of Blood Glucose for Patients with Type 1 Diabetes Mellitus

Embedded Model Predictive Control for a Wearable Artificial Pancreas

Zone Model Predictive Control with Glucose- and Velocity-Dependent Control Penalty Adaptation for an Artificial Pancreas.

Automated blood glucose regulation for nonlinear model of type-1 diabetic patient under uncertainties: GWOCS type-2 fuzzy approach

CHoKI-based MPC for blood glucose regulation in Artificial Pancreas

Adaptive Model Predictive Control with Particle Filter for Artificial Pancreas

Design of Robust Evolving Cloud-Based Controller for Type 1 Diabetic Patients Using n-Beats Algorithm

Optimized type-2 fuzzy controller based on IoMT for stabilizing the glucose level in type-1 diabetic patients